Stock Analiz

Kyverna Therapeutics, Inc. (KYTX) stock forecast and price target

Price $5.05 · data as of November 13, 2026

12-month price target

Average target$30.40
Upside / downside+502.0%
Analysts5
ConsensusStrong buy
Low $25.00Average $30.40High $33.00

Gold marker: average target · white marker: today’s price ($5.05)

Analyst ratings

Strong buy 2Buy 4Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.71+25.5%$0
Next fiscal year
ends December 31, 2027
$-3.04−12.0%$18M
Next quarter
ends December 31, 2026
$-0.76+5.5%$0
Quarter after
ends March 31, 2027
$-0.79—$500000

Consensus of the analysts covering Kyverna Therapeutics, updated daily. In the last 30 days 3 estimates were raised and 2 lowered.

Frequently asked questions

What is the Kyverna Therapeutics stock price target?

The average 12-month target from 5 analysts is $30.40, 502.0% above the current price of $5.05 Targets range from $25.00 to $33.00.

Is Kyverna Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 4 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Kyverna Therapeutics expected to earn?

Analysts expect EPS of $-2.71 for the fiscal year ending December 31, 2026 and $-3.04 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.